Trial Profile
A 24-week randomized controlled trial of VI-0521, a combination weight loss therapy, in obese adults.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2009
Price :
$35
*
At a glance
- Drugs Phentermine/topiramate (Primary) ; Phentermine; Topiramate
- Indications Obesity
- Focus Therapeutic Use
- 18 Oct 2007 New trial record.
- 10 May 2006 Results reported in a VIVUS media release.